Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Human immune phenotyping reveals accelerated aging in type 1 diabetes
Melanie R. Shapiro, … , Rhonda Bacher, Todd M. Brusko
Melanie R. Shapiro, … , Rhonda Bacher, Todd M. Brusko
Published July 27, 2023
Citation Information: JCI Insight. 2023;8(17):e170767. https://doi.org/10.1172/jci.insight.170767.
View: Text | PDF
Research Article Immunology

Human immune phenotyping reveals accelerated aging in type 1 diabetes

  • Text
  • PDF
Abstract

The proportions and phenotypes of immune cell subsets in peripheral blood undergo continual and dramatic remodeling throughout the human life span, which complicates efforts to identify disease-associated immune signatures in type 1 diabetes (T1D). We conducted cross-sectional flow cytometric immune profiling on peripheral blood from 826 individuals (stage 3 T1D, their first-degree relatives, those with ≥2 islet autoantibodies, and autoantibody-negative unaffected controls). We constructed an immune age predictive model in unaffected participants and observed accelerated immune aging in T1D. We used generalized additive models for location, shape, and scale to obtain age-corrected data for flow cytometry and complete blood count readouts, which can be visualized in our interactive portal (ImmScape); 46 parameters were significantly associated with age only, 25 with T1D only, and 23 with both age and T1D. Phenotypes associated with accelerated immunological aging in T1D included increased CXCR3+ and programmed cell death 1–positive (PD-1+) frequencies in naive and memory T cell subsets, despite reduced PD-1 expression levels on memory T cells. Phenotypes associated with T1D after age correction were predictive of T1D status. Our findings demonstrate advanced immune aging in T1D and highlight disease-associated phenotypes for biomarker monitoring and therapeutic interventions.

Authors

Melanie R. Shapiro, Xiaoru Dong, Daniel J. Perry, James M. McNichols, Puchong Thirawatananond, Amanda L. Posgai, Leeana D. Peters, Keshav Motwani, Richard S. Musca, Andrew Muir, Patrick Concannon, Laura M. Jacobsen, Clayton E. Mathews, Clive H. Wasserfall, Michael J. Haller, Desmond A. Schatz, Mark A. Atkinson, Maigan A. Brusko, Rhonda Bacher, Todd M. Brusko

×

Figure 5

Age- and T1D-associated phenotypes.

Options: View larger image (or click on image) Download as PowerPoint
Age- and T1D-associated phenotypes.
Rectangular Venn diagram summarizes ...
Rectangular Venn diagram summarizes phenotypes with unique association to age (left, blue shading) or T1D (right, yellow shading), with common phenotypes displayed in the overlapping area (center, green shading). The total number of phenotypes that are “unique” or “common” to age or T1D are indicated in parentheses. A color bar illustrating the magnitude and direction of effect for age or T1D is to the left of each phenotype (bar length represents the effect size; bar color indicates the phenotype is upregulated [yellow or red] or downregulated [gray or blue] in age or T1D, respectively). (See Figure 3A and Figure 4D.)

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts